Alza, Therapeutic Discovery Corp. deal

AZA exercised its option to acquire TDCA, a 1993 R&D spin-off, for $100

Read the full 135 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE